For the ULTIMATE review on all things pregnancy and IBD, check out this article in Nature Reviews Gastroenterology & Hepatology . Brilliant job by Max Brondfield, MD UCSF Health UCSFIBD rdcu.be/c8RIA

New milestone in CD therapy 👍

First human data on high conc. of #JAKinhibitors in breast milk: #tofacitinib is contraindicated during lactation. The Lancet Gastroenterology & Hepatology Great collaboration between IBD Leuven Uma Mahadevan Department of Hepatology and Gastroenterology, AUH Aarhus Uni.hospital PREDICT IBD Aarhus University

🗓️Calling on #IUS experts to Join us June 12 for the #MondayNightIBD convo led by Phillip Gu ! Exploring role of #IUS in #PostOp Crohns Rune Wilkens Bincy Abraham, MD, MS Noa Krugliak Cleveland, MD Kerri Mallory Chavannes, MD, MHSc Shellie Jean Radford Zedu Ultrasound Training @[email protected] Britt Christensen, MBBS MPH PhD Michael Todd Dolinger, MD MBA Bram Verstockt

The study highlights the consequences of metabolic syndrome on IBD. The visceral fat serves as a sump for anti-TNF’s and possibly other therapies by increasing systemic inflammation American Gastroenterological Association (AGA) Andres Yarur Oriana M. Damas, MD

Honoured to be talking in Singapore at AOCNR2023 on #ius in #IBD. IUS transforms patient care and so excited to see it becoming available worldwide. Thank-you to Elizabeth Cheong from SGH who trained The Royal Melbourne Hospital last year. Gastro and radiology collaborating 🤝 InternationalBowelUS

What a compelling talk by Dr Kate Goodall about her early onset bowel cancer diagnosis, it’s management & the impact on her personal life & career. 👏 Important message about the stigma associated with rectal bleeding; the symptom that people don’t want to talk about. #AGW2023

Not been overly productive recently but pleased to see my junior get his first author publication- molecular classification of Crohn’s Disease… are we ready? mdpi.com/2077-0383/12/1… with thanks to Britt Christensen, MBBS MPH PhD #shahedkamal and others.

New approach for refractory #Crohns, need RCTs SetPoint Medical #GeertDHaens Stephen B. Hanauer, MD Neuroimmune modulation through vagus nerve stimulation reduces inflammatory activity in Crohn’s disease patients: a prospective open-label study academic.oup.com/ecco-jcc/artic…

Important paper on consensus on histologic definitions in IBD. Was great to be part of this amazing collaboration

#IBDHorizons23 Laura Raffals, MD 🚨The greatest risk to pregnancy is active disease — not active medicine.” 🚨 🧑🏾‍⚕️Involve maternal fetal medicine 👩🏻‍⚕️Involve Colorectal surgeon 🤝Reassure the patient planning on becoming pregnant or who is already pregnant. #IBDPregnancy

By far the most important strategy in Crohn’s disease is to start an effective therapy early. It matters less which it is.

One of the great challenges in digestive disease is bringing complex data together for example, the ‘transmural revolution’ currently underway in #ibd with #IUS, endoscopy. Entrolytics brings this data together in research but from today is FDA registered for clinical use!

A great update on medical and dietary therapies in #CD for the general practitioner. From my wonderful fellow Alex Elford. medicinetoday.com.au/mt/2024/jan-fe…

Comprehensive review and update of stricturing Crohn’s disease Britt Christensen, MBBS MPH PhD #DrElford #DrArdalan Out on @IJG_Twitter #SpecialIBDissue link.springer.com/article/10.100…

On #worldibdday had wonderful time in Malaysia as speaker AbbVie Asian Multidisciplinary Interactive Symposium in Immunology (#MISI) talking about #treattotarget, #ius and jak-inhibitors in #IBD Rx. Hands on IUS workshops. Incredible meeting to improve patient care Prof Rupert Leong